Replies to post #220595 on Biotech Values

[WorstLuck]

Former DYAX shareholders get $4/sh CVR milestone payment from FDA approval of SHPG’s Takhzyro (f/k/a DX-2930) for HAE preventive use:

Anyone know when this payment is expected to show up? Still seeing CVR placeholder in account. TIA